Capital Research Global Investors

Position in PBH — Prestige Consumer Healthcare Inc.

CIK 1422848 Los Angeles, CA

Back to PBH Full portfolio

Position in PBH

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$53,027,624

+$18,388,875 QoQ

Shares Held

894,679

+59.3% QoQ

Ownership

1.89%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PBH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Capital Research Global Investors holds $573,348,010 across 3 Drug Manufacturers - Specialty & Generic names. PBH ranks #3 (9.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	19,104,219	$353,810,135
2	ZTS	Zoetis Inc.	1,408,597	$166,510,251
3	PBH	Prestige Consumer Healthcare Inc. This page	894,679	$53,027,624

All Filings in PBH

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$53,027,624	894,679	+59.3%	Shares	Defined	2026-05-13
2025-12-31	$34,638,749	561,497	+107.9%	Shares	Defined	2026-02-11
2025-09-30	$16,852,492	270,072	-8.7%	Shares	Defined	2025-11-13
2025-06-30	$23,628,413	295,910	—	Shares	Defined	2025-08-13
No filing history on record for this holder in this stock.